MedGenome invests into Gujarat-based diagnostics chain Green Cross to expand genomics offerings across India: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] MedG ...
TipRanks on MSN
CervoMed Gains FDA Alignment for Phase 3 Trial
CervoMed ( ($CRVO) ) has shared an announcement. On November 4, 2025, CervoMed Inc. announced it received alignment from the U.S. FDA on key ...
Lucknow: The National Medical Commission (NMC) has approved an increase of four PG seats each in three departments of KGMU)and granted permission to s.
The collaboration will strengthen Endeavor Health’s specialised, coordinated and accessible care for migraine treatment.
According to Mishra, the bacterial communities that establish in the first six to 12 months are responsible for allergy risk, ...
Palantir’s “ascent has confounded most financial analysts and the chattering class, whose frames of reference did not quite ...
FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application CervoMed is ...
Former NBA Player Tells Rutgers Health Students How He Rebounded From a Speech Impediment When former NBA player Michael Kidd-Gilchrist stepped into the classroom at Rutgers School of Health ...
Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity ...
Bengaluru (Karnataka) [India], November 4: MedGenome, a leading global genomics-driven diagnostics and research services company, has announced a majority investment in Gujarat-headquartered pathology ...
During Breast Cancer Awareness Month, the International Agency for Research on Cancer (IARC) is pleased to announce the ...
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results